Preference for biological motion is reduced in ASD: implications for clinical trials and the search for biomarkers.
Mason L, Shic F, Falck-Ytter T, Chakrabarti B, Charman T, Loth E, Tillmann J, Banaschewski T, Baron-Cohen S, Bölte S, Buitelaar J, Durston S, Oranje B, Persico AM, Beckmann C, Bougeron T, Dell'Acqua F, Ecker C, Moessnang C, Murphy D, Johnson MH, Jones EJH; LEAP Team*.
Mason L, et al.
Mol Autism. 2021 Dec 15;12(1):74. doi: 10.1186/s13229-021-00476-0.
Mol Autism. 2021.
PMID: 34911565
Free PMC article.